Journal of Viral Hepatitis commencing January 2015
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial
ITPA genetic variants influence efficacy of PEG-IFN/RBV therapy in older patients infected with HCV genotype 1 and favourable IL28B type
Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy
Long-term stimulation of Toll-like receptor 3 in primary human hepatocytes leads to sensitization for antiviral responses induced by poly I:C treatment
HLA-DQ polymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapy
Neutrophil–lymphocyte ratio: a novel predictor for short-term prognosis in acute-on-chronic hepatitis B liver failure
Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients
The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection
IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients
Role of IFN-λs , IFN-λs related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease
Infected hematopoietic stem cells and with integrated HBV DNA generate defective T cells in chronic HBV infection patients
The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia
High seroprevalence of hepatitis B virus and hepatitis C virus among human immunodeficiency virus carriers in blood donors of Burkina Faso: a need for their screening before HARRT therapy
Modified spleen stiffness measurement: a step forward, but still not the solution to all problems in the noninvasive assessment of cirrhotic patients